Skip to main content
. 2026 Apr 29;18(9):1423. doi: 10.3390/cancers18091423
AML Acute myeloid leukemia
allo-HSCT Allogeneic hematopoietic stem cell transplantation
BM Bone marrow
CR Complete remission
DEGs Differentially expressed genes
ES Enrichment score
FAB The French–American–British classification
GBP1 Guanylate-binding protein
IFN Interferon
IPA Ingenuity pathway analysis
ISGs Interferon stimulated genes
L-TME Leukemic bone marrow tumor microenvironment
MRD minimal residual disease
OS Overall survival
PARP12 Poly-ADP-ribose-polymerase-12 enzyme
PB Peripheral blood
RNA-Seq/mRNA-Seq mRNA-sequencing
ssGSEA Single-sample gene set enrichment analysis
TARGET Therapeutically Applicable Research to Generate Effective Treatments
TH1 T helper 1
TME Tumor microenvironment
TRAT1 T-cell receptor-associated transmembrane adapter
tSNE t-distributed stochastic neighbor embedding
WHO World Health Organization